November 2017 FDA Recall Penicillin V Potassium by Teva Pharmaceuticals Usa
D-0108-2018 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on November 28, 2017 for the product Penicillin V Potassium. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0108-2018

Reason for Recall
Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.
Initiated
11-28-2017
Reported
12-20-2017
Quantity
42,384 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Teva Pharmaceuticals USA
Nationwide in the USA and Puerto Rico.
Penicillin V Potassium for Oral Solution, USP, 125 mg (200,000 U) per 5 mL, 100 mL (when mixed) bottle, Rx only, Manufactured In Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454; NDC 0093-4125-73.

Batch or Lot Expiration Information

Lot# 35433115A, Exp 01/18